Search Results

Keyword: ‘allergan’

How to Operate a Successful Medical Spa – Myths Debunked

October 22nd, 2008

Medical_Spas_Profit.png

IAPAM Debunks Top 3 Medical Spa Myths

In today’s economy, and given the growth in accessibility and acceptance of aesthetic medicine procedures, it is very important that practitioners understand: “what is working” and “what is not” in their practices, in order to have a successful and profitable medical spa. Debunking the top 3 “Medical Spa Myths” may be all that is standing in the way of any practice from reaching its fullest potential.

The IAPAM (International Association for Physicians in Aesthetic Medicine) has reviewed its member profiles in order to identify some of the common traits among its most successful medical spas and aesthetic medicine practices.

Jeff Russell comments that, “In our research, we have found that Read more…

Med Spa, Medical Spa, Spa Business, Spa Industry

Botox and the Brain… New Study

April 9th, 2008

botox-injection-sites.png

This article is brought to you by Spavelous.com.

 

Botox can reach the brain, researchers say.

Botox injection Botox injected into face muscles can travel into the brain, according to a study of laboratory rats and mice published today in the Journal of Neuroscience.

Once it reaches the central nervous system, the diluted form of the botulinum toxin can disrupt nerve cell activity, said researcher Matteo Caleo of Italy’s National Research Council, who led the project.

The study is the latest of several raising questions about the safety of the wrinkle-fighter Botox, which is made by Irvine-based Allergan.

In February, the Food and Drug Administration launched a review of Botox, citing 16 cases of deaths of patients who had received injections of the toxin.

All but one of the deaths were related to strong therapeutic doses of botulinum toxin. Even the one death that followed six weeks after an injection of weaker cosmetic-strength Botox was not caused by that treatment, Allergan said.

Allergan notes that Botox has been used safely by millions of patients over the past two decades.

Local cosmetic physicians say they have seen no problems worse than an occasional headache among Botox users, and no evidence that patients are wary of the injections. Several said that the fact that the injected toxin travels within the body has long been known, and is a reason why skilled physicians calculate safe dosages and use appropriate injection methods.

The Journal of Neuroscience gave the article the label, “Could botulinum toxin be bad for you?”

In a press release on March 26, the Society for Neuroscience, which publishes the journal, said,

Botulinum neurotoxin disrupts cell communication by destroying a protein essential to signaling between nerve cells. Matteo Caleo, PhD, of Italy’s National Research Council, and colleagues confirmed the movement of botulinum neurotoxin A by detecting the remnants of proteins it had fragmented. This evidence helped show that nerve cells at the injection site absorbed some of the botulinum neurotoxin, which was then transported across the cell and released to connected cells, where the proteins also were destroyed. The direction it traveled was opposite to that of the nerve cell’s electrical signals. These findings contradict previous research, which suggested that botulinum neurotoxin was completely degraded at the injection site and not transported beyond it.

Caleo’s team traced the movement of botulinum neurotoxins in mice and rats. The team made injections into the whisker muscles, the hippocampus, and the superior colliculus, a brain region that receives input from the eye. Using protein analysis and microscopic examination of the rodents’ brain tissue, the researchers found that, within three days, active forms of botulinum neurotoxin had migrated from the whisker muscles to the brain stem, from one hippocampus to the hippocampus on the opposite side of the brain, and from the superior colliculus back to the eye.

Brain cell activity was disrupted both where botulinum neurotoxin was injected and in some of these distant but connected sites. Caleo and his colleagues noted in particular that the effects of the botulinum neurotoxin injection on the hippocampus were still present six months later.

In March, researchers in Canada found that injected Botox migrates to nearby muscles.(This post was updated at 5:45 p.m. to add links and expand the discussion of past studies and the new Italian research.)

 

Related Articles

 

Best Spa Locator / Anti Aging / Find a Med Spa / Facials

Spa Vacation FinderSpa Resort, Day Spa, Medical Spa

Botox, Med Spa, Medical Spa, Spa Safety, Spa Treatments

Does Botox weaken surrounding muscles – new research

March 13th, 2008

botox-injection-sites.png

 

Newly published research shows that Botox moves beyond its injection site and can weaken nearby muscles.

The study, conducted at the University of Calgary in Canada, adds to mounting evidence about unintended consequences of injections of Botox’s weakened version of botulinum toxin, at least in doses higher than those used to eliminate wrinkles.

Botox-maker Allergan of Irvine, meanwhile, notes that Botox has been used safely by millions of patients over the past two decades. Local doctors also report no problems.

Lead researcher Walter Herzog, co-director of Calgary University’s Human Performance Lab, told the Daily Mail newspaper in Britain, “What we found was that the toxin passed easily into the surrounding muscles and weakened all the muscles in the area. The results support other research that has already shown that botulinum can pass through muscle fascia (the packing tissue around muscles).”

“Our research showed that the toxin can also affect the working of the neighboring muscles,” he said.

In addition to its well-known uses as a wrinkle-fighter, Botox in stronger concentrations is used for an increasing number of muscle-related problems, including cerebral palsy, muscle rigidity after strokes, and muscle tightness that can cause incontinence or migraines.

“While I see the benefits of it as a therapeutic tool, its applications in humans are increasing and it is important we understand more about this product, which is a toxin,” Herzog said.

His study, which was published in the Journal of Biomechanics, involved Botox injections into cats.

Allergan spokesman Dr. Antony Fulford-Smith told the Daily Mail that evidence drawn from animal studies has limited application to humans.

“Dr. Herzog’s research was on cats and therefore it is inappropriate to make any conclusions at all about the safety of Botox in relation to humans,” he said. “It was a laboratory experiment using doses that would not normally be used in a therapeutic situation.”

“Botox has been used worldwide to treat millions of people for many conditions for nearly 20 years, providing huge relief in many cases. We closely monitor any adverse reactions and if used as indicated and injected in the right dose it is very rare for there to be any serious side-effects in relation to the spread of the toxin.”

Last month the Food and Drug Administration announced that 16 deaths occurred after patients were injected with Botox and a similar drug, Myobloc, which is not used as a cosmetic treatment. The FDA said it is reviewing safety warnings on those medications.

Only one of those deaths involved a patient who was injected with Allergan’s Botox Cosmetic. Her physician said the treatment did not cause the fatality, which occurred seven weeks afterwards.

Anti Aging, Health, Med Spa, Medical Spa, Spa

Botox-like drug without the needle is worth $20 million to Medicis

December 30th, 2007

medicis-scottsdale-az.png

Botox / Scottsdale AZ Medical Spas

 

This article is brought to you by Spavelous.com.

The allure of a potential Botox rival that goes on the skin without needing to be injected persuaded Medicis Pharmaceuticals to pay $20 million for about 10 percent of Revance Therapeutics.

The deal, announced Dec. 11, also gives Medicis of Scottsdale, Ariz., an option to buy the Mountain View-based company or to acquire an exclusive license for Revance’s experimental botulinum-toxin wrinkle-fighter in North America when the drug completes Phase 2 clinical trials.

Botox, made by Allergan of Irvine, is the No. 1 cosmetic medical treatment in the country, at about 4 million injection treatments last year for people seeking to smooth the lines in their faces.

“The early stage technology of Revance’s novel delivery of botulinum toxin type A topically for aesthetic purposes is of particular interest to us for our aesthetic product pipeline,” said Jonah Shacknai, chief executive of Medicis. We believe the application of botulinum toxin type A without an injection could dramatically expand the usage of the treatment, and expand the market even more rapidly than it is growing today.”

Medicis makes the No. 1 dermal filler, Restylane, and is seeking U.S. Food and Drug Administration approval for its own injectable version of the botulinum toxin.

Revance says its technology lets large drug molecules penetrate the skin. The company has exclusive worldwide rights to a highly purified version of botulinum toxin type A with a low molecular weight, Revance says.

 

 

Sign up for the Spavelous Weekly Free Spa Magazine and read the latest on Medical Spa Treatments in the first two January issues.

 

 

Press Release

 

 

 

Find a medspa / Medical spas in

Med Spa, Medical Spa